Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. - Wikidata - awgldk - TriplyDB

Cytokine targets in the brain: impact on neurotransmitters and neurocircuits.

Cytokine targets in the brain: impact on neurotransmitters and neurocircuits.

http://www.wikidata.org/entity/Q34078917

about

Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive Disorder Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review The Involvement of TNF-α in Cognitive Dysfunction Associated with Major Depressive Disorder: An Opportunity for Domain Specific Treatments Towards a personalized treatment in depression: endocannabinoids, inflammation and stress response Clinical Advances in Geriatric Psychiatry: A Focus on Prevention of Mood and Cognitive Disorders Psychobiotics and the Manipulation of Bacteria-Gut-Brain Signals Autonomic and inflammatory consequences of posttraumatic stress disorder and the link to cardiovascular disease Distinct plasma immune signatures in ME/CFS are present early in the course of illness The Depressed Frail Phenotype: The Clinical Manifestation of Increased Biological Aging.Maternal bisphenol a diet induces anxiety-like behavior in female juvenile with neuroimmune activation.Cytokine gene variations associated with subsyndromal depressive symptoms in patients with breast cancer Monitoring candidate gene expression variations before, during and after a first major depressive episode in a 51-year-old man.IFN-alpha-induced cortical and subcortical glutamate changes assessed by magnetic resonance spectroscopy.In immune defense: redefining the role of the immune system in chronic disease.Inflammation: opportunities for treatment stratification among individuals diagnosed with mood disorders.How Accurate Appraisal of Behavioral Costs and Benefits Guides Adaptive Pain Coping.Cytokine gene variations associated with trait and state anxiety in oncology patients and their family caregivers.Malaise, melancholia and madness: the evolutionary legacy of an inflammatory bias Genome-wide and gene-based association studies of anxiety disorders in European and African American samples Naproxen attenuates sensitization of depressive-like behavior and fever during maternal separation.Using biomarkers to predict treatment response in major depressive disorder: evidence from past and present studies.Altered inflammatory activity associated with reduced hippocampal volume and more severe posttraumatic stress symptoms in Gulf War veterans.Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder.Effect of 2 psychotherapies on depression and disease activity in pediatric Crohn's disease Behavioral Deficits Are Accompanied by Immunological and Neurochemical Changes in a Mouse Model for Neuropsychiatric Lupus (NP-SLE).Cost-utility and biological underpinnings of Mindfulness-Based Stress Reduction (MBSR) versus a psychoeducational programme (FibroQoL) for fibromyalgia: a 12-month randomised controlled trial (EUDAIMON study).Generation and Characterization of Mice Expressing a Conditional Allele of the Interleukin-1 Receptor Type 1.Increased Contextual Fear Conditioning in iNOS Knockout Mice: Additional Evidence for the Involvement of Nitric Oxide in Stress-Related Disorders and Contribution of the Endocannabinoid System Immune-to-Brain Communication Pathways in Inflammation-Associated Sickness and Depression.Cancer-related fatigue--mechanisms, risk factors, and treatments.Early-Life Adversity and Physical and Emotional Health Across the Lifespan: A Neuroimmune Network Hypothesis.Inflammation is increased with anxiety- and depression-like signs in a rat model of spinal cord injury.DICER1 and microRNA regulation in post-traumatic stress disorder with comorbid depression.Neural circuitry and immunity.Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients Val66Met BDNF polymorphism as a vulnerability factor for inflammation-associated depressive symptoms in women with breast cancer The Selective Serotonin Reuptake Inhibitor Citalopram Decreases Human Immunodeficiency Virus Receptor and Coreceptor Expression in Immune Cells.Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression.The role of cytokines in the pathophysiology of suicidal behavior.Programmed symptoms: disparate effects united by purpose.

P2860

Q26747511-3EA3EFB5-E3AB-45CB-B585-5D02CB8C4A11 Q26782993-4DC01651-DCE3-434E-9EC4-9A1217FCB68C Q26783012-3E288103-BC30-4589-ACA7-A81BC09B862D Q26851511-92740943-4099-4E04-A74A-2CBFDC4FFA3F Q27012619-C56E931A-951A-4C1C-8A42-89FF01920894 Q28078842-33A7DDF5-DA66-4815-BFDA-8143AEDF1B67 Q28081985-E0986F14-2682-44C3-9FC0-249BB4262D3D Q28263550-1CAA08FF-C8D0-413E-A411-2EB6E2531DF9 Q30244442-5C97343C-3BBD-4193-87CA-20D053B5AEAE Q30458124-ECC7F4AB-4D1C-439A-8E39-0A3AA0C2EA4B Q30581961-8C54B097-1410-492F-B916-A2EFB1DC85E8 Q31153904-818C23F2-260E-4D51-BC80-43BC14798C11 Q33620624-711737E1-377D-4514-A0EB-C8CD8CB8F277 Q33721014-965896E0-4E3E-4279-9846-D914BFB73853 Q33721019-441AD754-0A5B-4146-B46B-6FD80AD5BC9C Q33785851-A60A7927-6BB6-4C21-A9CC-EA5C0058C5CA Q33809141-AD07FC28-7343-4437-B29E-2E60668EB17A Q34342600-862B4F63-1D3E-427C-8758-1F644E44C3F1 Q34447563-17EE9E3D-C6A6-44BE-8618-1153BD28BCCB Q34765056-47BB5C0D-C2BF-4523-92F5-DD41A15CD59F Q35109175-68FE7DA6-B9FE-45D1-88F4-7ABF7210F8BC Q35219605-C5D9DA01-4840-4A44-8070-8F6FB5CDD475 Q35554351-6B2B9C7C-6751-4EC0-9C7E-F3009AD564FC Q35624810-6476C0C4-D8B1-4C61-9ED4-7F4674AA3221 Q35902490-AFC5E1C0-8DAD-4080-8F5A-AE766712333E Q35938110-685EE72D-3631-486E-ABB1-8544B6CA15C2 Q35941258-A9237D3F-908D-43B0-976A-25E90D90D211 Q36064473-C7450F1B-6D5E-4DC3-ADC8-A927FA56F89D Q36146367-814DCA89-3291-429E-8F16-53E46619A2E1 Q36332266-F7C95DC9-2816-45AD-BA33-FA74C32B3C42 Q36348331-BE0E6937-3BC2-41D7-8FA2-98AEE0581EA2 Q36373405-730D3724-DB2F-4064-B270-988544D30128 Q36392527-10BEAC3D-0982-430A-B444-B4AD71A6970F Q36551920-7F709940-CD6F-4B1E-A4CD-CBFD4881AA8D Q36634249-F7FCD927-F698-4153-91F4-3E526FDD0891 Q36813475-1DE2CDE5-F07A-4AD1-94AF-4D1518422C74 Q36889342-F851564C-59A4-4996-924B-9BD93BB0428B Q36905880-880CD221-7DDC-4D90-805C-FFFC57902F64 Q37013096-61BAD0E1-CB9C-4E2B-842C-0988FBF52B11 Q37204042-BEC78FC9-331A-462D-B1AE-7657A5E61AB6

P2860

Cytokine targets in the brain: impact on neurotransmitters and neurocircuits.

http://www.wikidata.org/entity/Q34078917

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Cytokine targets in the brain: impact on neurotransmitters and neurocircuits.

@ast

Cytokine targets in the brain: impact on neurotransmitters and neurocircuits.

@en

Cytokine targets in the brain: impact on neurotransmitters and neurocircuits.

@nl

type

label

Cytokine targets in the brain: impact on neurotransmitters and neurocircuits.

@ast

Cytokine targets in the brain: impact on neurotransmitters and neurocircuits.

@en

Cytokine targets in the brain: impact on neurotransmitters and neurocircuits.

@nl

prefLabel

Cytokine targets in the brain: impact on neurotransmitters and neurocircuits.

@ast

Cytokine targets in the brain: impact on neurotransmitters and neurocircuits.

@en

Cytokine targets in the brain: impact on neurotransmitters and neurocircuits.

@nl

P1433

Q34078917-C5CFE2FC-EBF4-4625-BA7F-51CAD3C7C1A2

P1476

Q34078917-95AEE041-D2DA-47B1-8418-BC1AF3DA5FA9

P2093

Q34078917-0F893963-A304-48CF-BD7A-C1E44DC57E15

Q34078917-195B881F-97F2-4B6A-B3BB-C4F640E07E24

Q34078917-23015888-1C0B-46DF-9D3B-1809ABE5282A

Q34078917-C6001F57-18E9-4518-8CD9-8C459A6AF329

P2860

Q34078917-0015EED7-7C60-410C-A673-FA39A890E1E3

Q34078917-01B46C22-6E01-4151-9BE5-CCA2ADFA2E06

Q34078917-02B4BB9A-B85A-4AB8-AB7F-AAE0B31BCD1A

Q34078917-0663B5B6-607A-414E-984F-2DC9216FE01B

Q34078917-081290EF-5F76-4789-9E42-521983DEF87E

Q34078917-092E1E9D-B09E-4C9A-A5D7-3CC4E248AAD2

Q34078917-0F29D45B-2853-4BB3-91F0-99F913391162

Q34078917-157863A8-DE89-4B36-AC9B-0E84F17102DC

Q34078917-17209304-EDC8-4E0E-B3CD-B40D212F8C2F

Q34078917-1A3F9CD3-049B-438D-93E0-378662938FC7

P304

Q34078917-E05B633D-81BE-42D9-9D1A-AEA78CCECE59

P31

Q34078917-5A9C9A0B-3939-4CC4-9FFD-2CAF98E304AC

P356

Q34078917-A02C7EA5-4A2C-4278-8AEC-2137631F3C64

P433

Q34078917-A6813992-4179-4956-A16D-BCF29A2081AD

P478

Q34078917-97B8EB4B-FA74-4656-89F6-F59340E9A8C5

P577

Q34078917-D7F5A8F9-4D3B-4D6E-8425-3C744DE0C45D

P5875

Q34078917-E82F4A00-8C79-49C4-800F-20A87A392E1F

P698

Q34078917-E2703EDE-B84E-44F5-BFCE-050658F70135

P921

Q34078917-920B4341-79FE-4ED5-8DDF-C3FCCB850486

P932

Q34078917-FBF7E0C0-4372-4A0E-85B7-50587F691EF6

P356

P1433

Depression and Anxiety

P1476

Cytokine targets in the brain: impact on neurotransmitters and neurocircuits.

@en

P2093

Andrew H Miller

http://www.w3.org/2001/XMLSchema#string

Charles L Raison

http://www.w3.org/2001/XMLSchema#string

Ebrahim Haroon

http://www.w3.org/2001/XMLSchema#string

Jennifer C Felger

http://www.w3.org/2001/XMLSchema#string

P2860

Neural sensitivity to social rejection is associated with inflammatory responses to social stress

Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans

Cytokines sing the blues: inflammation and the pathogenesis of depression

From inflammation to sickness and depression: when the immune system subjugates the brain

Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity

When grief heats up: pro-inflammatory cytokines predict regional brain activation

Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior

Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment

Acetylsalicylic acid accelerates the antidepressant effect of fluoxetine in the chronic escape deficit model of depression

Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study

P304

297-306

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/DA.22084

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235882265

http://www.w3.org/2001/XMLSchema#string

P698

23468190

http://www.w3.org/2001/XMLSchema#string

P921

neurotransmitter

P932

4141874

http://www.w3.org/2001/XMLSchema#string